Shattuck Labs, Inc. SEC filings STTK
Shattuck Labs, Inc. has 413 filings in SEC EDGAR's recent list, going back to Jul 28, 2016. Its latest annual report, Form ARS, was filed on Apr 8, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 5, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 5, 2026 (results of operations). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Results of operations
|
Nov 5, 2026 | Nov 5, 2026 |
| 8-K |
Current report
Results of operations
|
Aug 11, 2026 | Aug 11, 2026 |
| 8-K |
Current report
Material agreement
|
Jun 11, 2026 | Jun 9, 2026 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Jun 9, 2026 | Jun 8, 2026 |
| 8-K |
Current report
Officer or director change, Shareholder vote results
|
Jun 2, 2026 | May 28, 2026 |
| 8-K |
Current report
Results of operations
|
May 7, 2026 | May 7, 2026 |
| 8-K |
Current report
Results of operations
|
Mar 5, 2026 | Mar 5, 2026 |
| 8-K |
Current report
Other events
|
Feb 5, 2026 | Feb 5, 2026 |
| 8-K |
Current report
Material agreement
|
Jan 22, 2026 | Jan 22, 2026 |
| 8-K/A |
Amended current report
Results of operations
|
Nov 6, 2025 | Nov 6, 2025 |
| 8-K |
Current report
Results of operations
|
Nov 6, 2025 | Nov 6, 2025 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Aug 26, 2025 | Aug 25, 2025 |
| 8-K |
Current report
Results of operations
|
Aug 14, 2025 | Aug 14, 2025 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Regulation FD disclosure
|
Aug 5, 2025 | Aug 4, 2025 |
| 8-K |
Current report
Shareholder vote results
|
Jul 15, 2025 | Jul 10, 2025 |
| 8-K |
Current report
Results of operations
|
May 1, 2025 | May 1, 2025 |
| 8-K |
Current report
Results of operations
|
Mar 27, 2025 | Mar 27, 2025 |
| 8-K |
Current report
Results of operations
|
Nov 14, 2024 | Nov 14, 2024 |
| 8-K |
Current report
Agreement ended, Exit or restructuring costs, Other events
|
Oct 1, 2024 | Sep 30, 2024 |
| 8-K |
Current report
Results of operations
|
Aug 1, 2024 | Aug 1, 2024 |
| 8-K |
Current report
Regulation FD disclosure
|
Jun 14, 2024 | Jun 14, 2024 |
| 8-K/A |
Amended current report
Officer or director change
|
Jun 11, 2024 | Mar 1, 2024 |
| 8-K |
Current report
Shareholder vote results
|
Jun 10, 2024 | Jun 7, 2024 |
| 8-K |
Current report
Results of operations
|
May 2, 2024 | May 2, 2024 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Mar 4, 2024 | Mar 1, 2024 |
| 8-K |
Current report
Results of operations
|
Feb 29, 2024 | Feb 29, 2024 |
| 8-K |
Current report
Material agreement
|
Feb 13, 2024 | Feb 9, 2024 |
| 8-K |
Current report
Material agreement, Unregistered share sale
|
Dec 22, 2023 | Dec 21, 2023 |
| 8-K |
Current report
Other events
|
Dec 21, 2023 | Dec 21, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Dec 13, 2023 | Dec 13, 2023 |
| 8-K |
Current report
Results of operations
|
Nov 9, 2023 | Nov 9, 2023 |
| 8-K |
Current report
Results of operations
|
Aug 10, 2023 | Aug 10, 2023 |
| 8-K |
Current report
Shareholder vote results
|
May 24, 2023 | May 23, 2023 |
| 8-K |
Current report
Results of operations
|
May 9, 2023 | May 9, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Mar 10, 2023 | Mar 10, 2023 |
| 8-K |
Current report
Results of operations
|
Feb 23, 2023 | Feb 23, 2023 |
| 8-K |
Current report
Results of operations
|
Nov 8, 2022 | Nov 8, 2022 |
| 8-K |
Current report
Results of operations
|
Aug 11, 2022 | Aug 11, 2022 |
| 8-K |
Current report
Material agreement
|
Jul 29, 2022 | Jul 29, 2022 |
| 8-K |
Current report
Shareholder vote results
|
Jun 10, 2022 | Jun 7, 2022 |
| 8-K |
Current report
Results of operations
|
May 12, 2022 | May 12, 2022 |
| 8-K |
Current report
Results of operations
|
Mar 15, 2022 | Mar 15, 2022 |
| 8-K |
Current report
Regulation FD disclosure
|
Nov 15, 2021 | Nov 12, 2021 |
| 8-K |
Current report
Results of operations
|
Nov 9, 2021 | Nov 9, 2021 |
| 8-K |
Current report
Officer or director change
|
Oct 28, 2021 | Oct 22, 2021 |
| 8-K |
Current report
Results of operations
|
Aug 11, 2021 | Aug 11, 2021 |
| 8-K |
Current report
Shareholder vote results
|
Jun 10, 2021 | Jun 8, 2021 |
| 8-K |
Current report
Results of operations
|
May 10, 2021 | May 10, 2021 |
| 8-K |
Current report
Results of operations
|
Mar 15, 2021 | Mar 15, 2021 |
| 8-K |
Current report
Results of operations
|
Nov 13, 2020 | Nov 13, 2020 |
| 8-K |
Current report
Bylaw or fiscal year change
|
Oct 14, 2020 | Oct 14, 2020 |
Showing 51 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- STTK (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Austin, TX
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1680367
- Former names
- Shattuck Labs, Inc. (until Nov 5, 2026)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.